IgG2b inducing factor from rheumatoid arthritis synovial fluid synergizes with transforming growth factor-β in promoting IgG2b antibody production in mouse B lymphocytes

Scandinavian Journal of Immunology

Volumn 45, Issue 1, 1997, Pages 50-54

  Lettesjo H ^a   Ridderstad, A ^a   Moller E ^b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

EID: 0031032001     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-372.x     Document Type: Article

References (28)

1. Andersson J, Sjöberg O, Möller G. Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur J Immunol 1972;2:349-53.
2. Slack J, Der-Balian GP, Nahm M, Davie JM. Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an x-linked immunodeficiency. J Exp Med 1980;151:853-62.
3. Izui S, Eisenberg RA, Dixon FJ. Subclass-restricted IgG polyclonal antibody production in mice injected with lipid A-rich lipopolysaccharides. J Exp Med 1981;153:324-38.
4. Isakson PC, Puré E, Vitetta ES, Krammer PH. T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. J Exp Med 1982;155:734-48.
5. Snapper CM, Paul WE. Interferon-γ and B cell stimulatory factor-I reciprocally regulate Ig isotype production. Science 1987;236:944-7.
6. Coffman RL, Lebman DA, Shrader B. Transforming growth factor β specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 1989;170:1039-44.
7. Sonoda E, Matsumoto R, Hitoshi Y et al. Transforming growth factor β induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med 1989;170:1415-20.
8. 1 selectively stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J Exp Med 1993;177: 1031-7.
9. Ridderstad A, Lettesjö H, Abedi-Valugerdi M, Möller E. Differential sensitivity to transforming growth factor (TGF)-β of CBA and of CBA/N B cells demonstrates that the IgG2b inducing factor in synovial fluid from rheumatoid arthritis patients is not identical to TGF-β. Int Immunol 1995;7:459-69.
10. Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor-β: biological function and chemical structure. Science 1986;233:532-4.
11. Childs CB, Proper JA, Tucker RF, Moses HL. Serum contains a platelet-derived transforming growth factor. Proc Natl Acad Sci USA 1982;79:5312-16.
12. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J Immunol 1986;137: 3855-60.
13. Kehrl JH, Wakefield LM, Roberts AB et al. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163: 1037-50.
14. Assoian RK, Fleurdelys BE, Stevenson HC et al. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987;84:6020-4.
15. Miyazono K, Ichijo H, Heldin C-H. Transforming growth factor-β: latent forms, binding proteins and receptors. Growth Factors 1993;8: 11-22.
16. Islam KB, Nilsson L, Sideras P, Hammarström L, Smith CIE. TGF-β1 induces germ-line transcripts of both IgA subclasses in human B lymphocytes. Int Immunol 1991;3:1099-106.
17. Snapper CM, Waegell W, Beernink H, Dasch JR. Transforming growth factor-β1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro. J Immunol 1993;151:4625-36.
18. Lettesjö H, Möller E. IgG2b inducing factor from rheumatoid arthritis synovial fluid activates antibody production in highly purified mouse B lymphocytes. Scand J Immunol 1997;45:43-9.
19. Ridderstad A, Abedi-Valugerdi M, Ström H, Möller G, Möller E. Rheumatoid synovial fluid reconstitutes the B-cell defect in CBA/N mice. Scand J Immunol 1989;30:749-53.
20. Karasuyama H, Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur J Immunol 1988; 18:97-104.
21. Dasch JR, Pace DR, Waegell W, Inenaga D, Ellingsworth L. Monoclonal antibodies recognizing transforming growth factor-β. Bioactivity neutralization and transforming growth factor β2 affinity purification. J Immunol 1989;142:1536-41.
22. O'Garra A, Stapleton G, Dhar V et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. Int Immunol 1990;2:821-32.
23. O'Garra A, Chang R, Go N, Hastings R, Haughton G, Howard M. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 1992;22:711-17.
24. Hayakawa K, Hardy RR, Herzenberg LA. Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur J Immunol 1986;16:450-6.
25. Pecanha LMT, Snapper CM, Lees A, Mond JJ. Lymphokine control of type 2 antigen response. IL-10 inhibits IL-5-but not IL-2-induced Ig secretion by T cell-independent antigens. J Immunol 1992;148: 3427-32.
26. Pecanha LMT, Snapper CM, Lees A, Yamaguchi H, Mond JJ. IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. J Immunol 1993;150:3215-23.
27. Van Vlasselaer P, Borremans B, van Gorp U, Dasch JR, De Waal-Malefyt R. Interleukin 10 inhibits transforming growth factor-β (TGF-β) synthesis required for osteogenic commitment of mouse bone marrow cells. J Cell Biol 1994:124:569-77.
28. Go NF, Castle BE, Barrett R et al. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of x chromosome-linked immunodeficiency B cells. J Exp Med 1990;172:1625-31.